Literature DB >> 31134677

Overexpression of miR-224-3p alleviates apoptosis from cerebral ischemia reperfusion injury by targeting FIP200.

Yiming Deng1,2,3, Gaoting Ma1,2,3, Qihao Dong4, Xuan Sun1,2,3, Lian Liu1,2,3, Zhongrong Miao1,2,3, Feng Gao1,2,3.   

Abstract

AIMS: In previous studies, numerous differential microRNAs (miRNAs) in cerebral ischemic/reperfusion (I/R) injury were identified using the miRNA microarray analysis. However, the relationship between miRNA and cerebral I/R injury remains largely unknown. In this study, we investigated the function and explored the possible mechanism of miR-224-3p in cerebral I/R injury.
METHODS: Oxygen glucose deprivation model in N2a cells were used to perform the cerebral I/R injury in vitro. Trypan blue staining, reactive oxygen species (ROS) production, and caspase-3 were measured to evaluate the function of miR-224-3p.
RESULTS: Overexpression of miR-224-3p alleviated the apoptosis induced by oxygen glucose deprivation (OGD) and cleaved caspase-3 was significantly reduced. We further provided the possible mechanism that miR-224-3p may protect cells from cerebral I/R injury by targeting FAK family-interacting protein (FIP200). Further rescue experiment proved that overexpression of FIP200 partially blocked the effect of miR-224-3p.
CONCLUSIONS: We evaluated the function and mechanism of miR-224-3p in ischemic brain injury. miR-224-3p may serve as a potential target for new therapeutic intervention.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  FIP200; apoptosis; ischemic stroke; miR-224-3p

Year:  2019        PMID: 31134677     DOI: 10.1002/jcb.28975

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  Overexpression of miR-149-5p Attenuates Cerebral Ischemia/Reperfusion (I/R) Injury by Targeting Notch2.

Authors:  Xiaoya Wang; Qingbao Xu; Shali Wang
Journal:  Neuromolecular Med       Date:  2021-09-28       Impact factor: 4.103

Review 2.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

3.  Down-regulating microRNA-20a regulates CDH1 to protect against cerebral ischemia/reperfusion injury in rats.

Authors:  Chun-Chun Yang; Xiang-Pin Wei; Xian-Ming Fu; Ling-Tao Qian; Lan-Jun Xie; Hong-Bo Liu; Gang Li; Xin-Gang Li; Xian-Wei Zeng
Journal:  Cell Cycle       Date:  2020-12-19       Impact factor: 4.534

4.  MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities.

Authors:  Yaoran Tu; Yong Hu
Journal:  Metab Brain Dis       Date:  2021-04-12       Impact factor: 3.655

5.  Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro.

Authors:  Zhaohui Chai; Jiangbiao Gong; Peidong Zheng; Jiesheng Zheng
Journal:  Biol Res       Date:  2020-04-20       Impact factor: 5.612

6.  Low expression of miR‑532‑3p contributes to cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2.

Authors:  Li Mao; Mei-Ling Zuo; Ai-Ping Wang; Ying Tian; Li-Chen Dong; Tao-Ming Li; Da-Bin Kuang; Gui-Lin Song; Zhong-Bao Yang
Journal:  Mol Med Rep       Date:  2020-07-10       Impact factor: 2.952

7.  HDAC1-mediated deacetylation of HIF1α prevents atherosclerosis progression by promoting miR-224-3p-mediated inhibition of FOSL2.

Authors:  Hao Wang; Kazuo Sugimoto; Hao Lu; Wan-Yong Yang; Ji-Yue Liu; Hong-Yu Yang; Yue-Bo Song; Dong Yan; Tian-Yu Zou; Si Shen
Journal:  Mol Ther Nucleic Acids       Date:  2020-11-05       Impact factor: 8.886

8.  MiR-195-5p Ameliorates Cerebral Ischemia-Reperfusion Injury by Regulating the PTEN-AKT Signaling Pathway.

Authors:  Xiaoli Ren; Zhiyun Wang; Congfang Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-29       Impact factor: 2.570

Review 9.  NLRC5: A Potential Target for Central Nervous System Disorders.

Authors:  Lu Zhang; Cui Jiao; Lingjuan Liu; Aiping Wang; Li Tang; Yi Ren; Peng Huang; Jie Xu; Dingan Mao; Liqun Liu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

10.  NLRC5 alleviated OGD/R-induced PC12-cell injury by inhibiting activation of the TLR4/MyD88/NF-κB pathway.

Authors:  Zhen Zhang; Yuhan Sun; Xin Chen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.